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Abstract 1 
Aldosterone-producing adenoma and bilateral adrenal hyperplasia account for more than 90% of all 2 
primary aldosteronism cases. Distinguishing between bilateral and unilateral disease is of 3 
fundamental importance because it allows targeted therapy. Adrenal vein sampling is the only reliable 4 
means to preoperatively differentiate between unilateral and bilateral subtypes. A very rare but 5 
serious complication of adrenal vein sampling is an adrenal haemorrhage. We retrospectively 6 
examined in detail 24 cases of adrenal  haemorrhage during adrenal vein sampling in 6 different 7 
referral hypertension centers. Adrenal haemorrhage more often affected the right adrenal (n=18) than 8 
the left (n=5, P<0.001; 1 bilateral). Median duration of experience of the radiologist in adrenal vein 9 
sampling at the time of adrenal haemorrhage was 5.0 years [0.6-7.8] and adrenal haemorrhage 10 
occurred with both highly experienced (>10 yrs) and less experienced radiologists. Of 9 patients who 11 
suffered adrenal haemorrhage in the gland contralateral to an aldosterone-producing adenoma and 12 
who underwent complete (n=6) or partial (n=3) unilateral adrenalectomy, only one required long-13 
term corticosteroid replacement for adrenal insufficiency. No reduction in blood pressure or 14 
biochemical resolution of primary aldosteronism occurred in any of those patients who experienced 15 
adrenal haemorrhage in the gland ipsilateral to an aldosterone-producing adenoma (n=6) or who had 16 
bilateral adrenal hyperplasia (n=9). No patient required invasive treatments to control bleeding or 17 
blood transfusion. In conclusion, adrenal haemorrhage usually has a positive outcome causing either 18 
no or minor effects on adrenal function and adrenal vein sampling should remains the best approach 19 
to primary aldosteronism subtype differentiation. 20 
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Introduction 1 
Studies both in vivo and in vitro have demonstrated that aldosterone plays a detrimental role on the 2 
cardiovascular system and patients affected by primary aldosteronism (PA) have an increased rate of 3 
cardio- and cerebro-vascular complications compared to essential hypertensives with a similar blood 4 
pressure levels (1, 2). In light of these considerations, the early identification of PA is crucial to enable 5 
targeted treatment to reverse the excess of organ damage in affected patients. As detailed by the 6 
Endocrine Society (3) and by the Japanese Endocrine Society Guidelines (4), optimal management 7 
of PA patients is dependent on the differentiation between aldosterone-producing adenoma (APA) 8 
and bilateral adrenal hyperplasia (BAH), the two most common subtypes of sporadic PA.  9 
Adrenal CT scanning with contrast and fine cuts is recommended in all confirmed PA patients to rule 10 
out malignancy (aldosterone-producing adrenocortical carcinoma), but it is otherwise unreliable for 11 
subtype differentiation since it lacks both sensitivity and specificity. In particular, micro-adenomas 12 
(< 1 cm in diameter) can be overlooked and it is not possible to distinguish between non-secreting 13 
incidentalomas and APAs by adrenal CT scanning alone (3,5). 14 
Adrenal vein sampling (AVS) is a demanding procedure consisting of the selective cannulation of the 15 
adrenal veins to identify the source of aldosterone overproduction. It was first described in the 1960s 16 
as a technique to localize APAs preoperatively (6), but its inherent invasiveness, lack of standardized 17 
criteria for interpretation of the hormonal results and the reported high complication rates at that time 18 
were major factors in hindering its employment in the clinical management of PA. A complication of 19 
AVS is adrenal haemorrhage (AH), secondary to adrenal vein rupture or, less frequently, to 20 
dissection, infarction or thrombosis (7).  21 
Historically, complication rates ranged between 5% to 10% and were reportedly associated with 22 
complete and permanent destruction of the gland (8-10). More recent studies, however, report a 23 
substantially lower rate of complications of between 0.2 to 0.9% (7,11). In part, this is likely to be 24 
related to the advent of CT for the imaging of adrenal lesions and the consequent abandonment of the 25 
practice of retrograde adrenal venography which required injection of a relatively large amount of 26 
 5 
contrast under considerable pressure, and was associated with an increased risk of AH (7). 1 
Interestingly, a recent observational, retrospective, multicenter study demonstrated that the rate of 2 
adrenal vein rupture was not predicted by the method of cannulation, but rather by the experience of 3 
the radiologist, that is, the number of AVS performed by each radiologist (7). 4 
Despite an impressive number of studies comparing the performances of imaging techniques and 5 
AVS in the subtype differentiation of PA (12), a systematic study on AH has never been performed 6 
and uncertainties in the clinical management of this complication still remain. The aim of this study 7 
was to describe the clinical presentation, management and outcome of 24 AH cases, collected from 6 8 
different tertiary referral hypertension centers, to help clinicians decide whether to use AVS in their 9 
PA patients. 10 
 11 
Materials and methods. 12 
Patients selection. 13 
We retrospectively evaluated 24 cases of adrenal haemorrhage following AVS that occurred in 6 14 
tertiary referral hypertension centers in Italy (Torino, 1994-01/2015, 427 AVS; Verona, 2009-2014, 15 
31 AVS), Germany (Munich, 12/2009-01/2015, 255 AVS; Wuerzburg 12/2009-01/2015, 69 AVS), 16 
Japan (Sendai, 04/2007-12/2014, 640 AVS) and Australia (Brisbane, 1990-2014, 1446 AVS).  17 
The control group comprised 1388 PA patients who underwent AVS in the different centres 18 
participating in the study, during a similar period of time as when the patients experienced AH during 19 
AVS (supplemental Table S1).  20 
The diagnosis of PA was made according to the Endocrine Society and the Japanese Endocrine 21 
Society Guidelines (3,4). Confirmatory testing and synacthen test were performed as detailed 22 
elsewhere (13-15). 23 
 6 
All patients included in the analysis gave written informed consent and approval from the local ethics 1 
committees was obtained for the use of these retrospective data. The study adhere to the principles of 2 
the Declaration of Helsinki and and to institutional guidelines. 3 
An expanded methods section is given in the supplemental file.  4 
 5 
Statistical analyses 6 
IBM SPSS Statistics 19 (SPSS INC, Chicago, IL) was used for statistical analyses. Data are presented 7 
as mean ± standard error or median (25th-75th percentile). Data were analyzed with the Kolmogorov-8 
Smirnov and Shapiro-Wilk tests to determine their distributions. Statistical significance between 9 
groups was calculated in normally distributed data by a Student t test for independent samples and in 10 
not normally distributed data by the Kruskal-Wallis test, using Bonferroni corrections for multiple 11 
comparisons. The chi-square test of the Fisher exact test were used for qualitative variables. A 12 
probability value of less than 0.05 was  considered statistically significant. 13 
 14 
Results. 15 
General description of the cases. 16 
We retrospectively identified 24 cases of adrenal haemorrhage that occurred during AVS in 6 17 
different referral hypertension centers in Italy, Germany, Japan and Australia. Clinical and 18 
biochemical characteristics (before and after AVS) of the patients included in the study are 19 
summarized in Tables 1 and 2. 20 
In our series, AH was more frequent in the right adrenal (n=18) than in the left (n=5, P<0.001), and 21 
in one case AH was bilateral. In one case (MU-01) the patient was referred for super-selective adrenal 22 
vein sampling because of bilateral nodules at adrenal computed tomography (CT) scanning but lack 23 
of lateralization at previous, non-selective AVS.  Haemorrhage occurred during the catheterization of 24 
side branches of the right adrenal vein. AVS showed highest aldosterone/cortisol-ratios in a vein 25 
draining the lateral limb of the right adrenal which bore an adenoma. In another case of right AH 26 
 7 
(BR-1), for the AVS procedure, gadolinium was used instead of iodinated contrast due to concerns 1 
about contrast allergy.  2 
CT scanning of a patient (TO-01) with right AH and left APA is shown is figure 1. 3 
Patients experiencing AH were older than patients who underwent uncomplicated AVS procedures. 4 
None of the other assessed clinical or biochemical and hormonal parameters were significantly 5 
different between the AH and the controls (supplemental table 1). Of the 24 patients included in the 6 
study, two were taking aspirin 100 mg/day (WU-01 and MU-03) one of whom was also under 7 
treatment with enoxaparin 0.4 mg (MU-03) (of note the percentage of patients on aspirin was not 8 
significantly different from the percentage of total PA patients receiving aspirin treatment within the 9 
Torino unit; data not shown); no other patients were receiving medications that are likely to have 10 
affected coagulation or platelet aggregation thereby facilitating the occurrence of AH. In our series 11 
there were no significant comorbidities other than diabetes in one patient (BR-10) and polymyalgia 12 
rheumatica treated with steroids in another (MU-03).  13 
According to AVS results, the final diagnosis was bilateral adrenal hyperplasia in 9 patients, left APA 14 
in 8 patients and right APA in 7 patients. In two patients (BR-7 and SE-03) the first AVS was not 15 
diagnostic: in BR-7 the right adrenal vein was not cannulated and in SE-03 the AVS was stopped 16 
after the occurrence of adrenal vein rupture. Repeated AVS revealed a final diagnosis of BAH in SE-17 
03 and left APA in BR-7.  18 
The median duration of experience of the radiologist in AVS at the occurrence of the AH was 5.0 19 
years [0.6-7.8, 25th-75th percentile] and, at the time of AH, 33% (8/24) of the radiologists performed 20 
less than 10 AVS/year, while 67% (16/24) performed more than 10 AVS/year. 21 
In all but 2 patients, the occurrence of AH required hospitalization or a prolongation of hospital stay 22 
compared to non-complicated procedures for an average of 1.9±1.3 days. Overall 54% (13/24) of the 23 
patients required the administration of a strong opioid (morphine, pethidine, piritramide, fentanyl) for 24 
efficient pain management, 8% required the administration of a weak opioid (codeine, tramadol), 25 
while 38% (9/24) required no analgesic medications. After the diagnosis of AH, adrenal CT was 26 
 8 
performed in 16 patients, one of whom also underwent NP-59 adrenal scintigraphy, to evaluate the 1 
residual activity of the affected adrenal gland. In 8 patients imaging was not performed. In our series 2 
none of the patients required invasive treatments to control bleeding or blood transfusion because of 3 
anaemia. 4 
Final diagnosis of unilateral PA, AH contralateral to the adenoma. 5 
Of the 15 patients displaying unilateral disease, AH occurred in the contralateral side to the adenoma 6 
in 9 cases. None of the 9 patients with AH contralateral to the side of lateralization showed BP 7 
reduction after the occurrence of the AH. Three of these 9 patients underwent nodulectomy and 6 8 
underwent total laparoscopic adrenalectomy. In all patients who underwent total adrenalectomy and 9 
had AH contralateral to the adenoma, adrenal function was tested to rule out adrenal insufficiency. 10 
Plasma cortisol at 8:00 a.m. was within the normal range (5-25 mg/dL) in all patients; rapid synacthen 11 
test was normal in five of the six tested patients (normal values > 500 nmol/L, 18.1 mcg/dL). In two 12 
patients (with right AH, BR-01 and BR-10) left adrenalectomy was performed under hydrocortisone 13 
cover. In the immediate post-operative period, patient BR-10 received ongoing treatment with 14 
dexamethasone while undergoing a short synacthen test (which showed a very blunted response from 15 
<35 to 83 nmol/L) followed by a “long synacthen test” (0900h cortisol levels basally and daily for 16 
two days after commencement of intramuscular depot tetracosactrin, 1 mg 12 hourly). Because the 17 
latter demonstrated a definite (albeit modest) cortisol response (from <35 to 306 nom/L by day 1 and 18 
271 nmol/l by day 2), dexamethasone was gradually withdrawn but an adrenal crisis occurred 19 
following subsequent shoulder surgery and the patient was therefore commenced (and remains) on 20 
cortisol and fludrocortisone supplementation. In patient BR-01 the test was performed 5 days after 21 
adrenalectomy and demonstrated a sub-normal response (from 303 to 484 nmol/L) and he therefore 22 
remained on glucocorticoid supplementation with plans for repeat testing in six weeks’ time. Adrenal 23 
function was also assessed in all patients who underwent nodulectomy (n=3) (in one case, WU-01 the 24 
tests were performed and reported as normal, but hormonal values were not available) and was found 25 
to be normal in each case (in BR-11 short synacthen test 1 month after adrenalectomy showed a 26 
 9 
partially blunted response after 60 minutes; the test was repeated 4 months later and showed an 1 
adequate response). In one patient (TO-01) NP-59 adrenal scintigraphy performed without 2 
dexamethasone suppression demonstrated a focus of tracer uptake by the right adrenal in agreement 3 
with residual right adrenal cortex function (Supplemental Figure S3): this patient had a normal 4 
synacthen test after nodulectomy. Of the three patients who underwent nodulectomy, two became 5 
normotensive without any anti-hypertensive medication and one displayed significant improvement 6 
of hypertension (normotensive on irbesartan 150 mg/day, before adrenalectomy SBP 180 mmHg, 7 
DBP 100 mmHg on three anti-hypertensive medications). Of the 6 patients who underwent total 8 
unilateral adrenalectomy, one displayed long-term adrenal insufficiency (BR-10) but BR-01, who 9 
demonstrated a blunted cortisol response to synacthen in the early post-operative period requires 10 
repeat testing to assess whether normal adrenal function has returned (adrenalectomy performed in 11 
March 2015).  Four patients were cured of PA and hypertension, 1 displayed significant amelioration 12 
of blood pressure levels and biochemical cure of PA and 1 was operated only in March 2015 and has 13 
not been fully re-evaluated after the operation. 14 
Final diagnosis of unilateral PA, AH ipsilateral to the adenoma. 15 
Of the 15 patients displaying unilateral disease, AH occurred in the side of the adenoma in 6 cases. 16 
According to the historical reports indicating permanent adrenal dysfunction after AH, we would 17 
have expected that AH in the side of the adenoma to have resulted in cure of PA without further 18 
treatment. However in our series, none of the patients displayed cure of PA or improvement of 19 
hypertension following AH, and all patients therefore still required unilateral adrenalectomy. 20 
Consistently, aldosterone levels did not change significantly after the AH but before the 21 
adrenalectomy in the four out of six patients who had the hormone tested (Supplemental Table S2). 22 
The occurrence of the AH was confirmed in all cases by histology report, clearly showing presence 23 
of recent bleeding in both the tumor and the adjacent adrenal tissue. None of these patients had 24 
evidence of adrenal insufficiency, as expected.  25 
Final diagnosis of BAH. 26 
 10 
In a recent report, hypertension was improved in 14 of 40 patients with BAH who underwent 1 
unilateral adrenalectomy (16). We analyzed the post-AVS parameters of the 9 BAH patients who 2 
experienced unilateral AH. Of note, none of the patients displayed any degree of blood pressure 3 
reduction or amelioration of PA after unilateral AH. As expected, we did not detect signs or symptoms 4 
of adrenal insufficiency in these patients. 5 
 6 
Discussion. 7 
The diagnosis of PA is a three step process (screening, confirmation and subtype differentiation) and 8 
AVS is recognized by the Endocrine Society and Japanese Endocrine Society Guidelines (3,4) as the 9 
gold standard test to distinguish between unilateral and bilateral disease. It is a demanding 10 
interventional procedure where the adrenal veins are accessed through a femoral vein approach and 11 
cannulated to identify the source of aldosterone overproduction. The left adrenal vein almost always 12 
drains into the left renal vein and it is therefore usually relatively easy to cannulate. On the contrary, 13 
the right adrenal vein is small, drains directly into the inferior vena cava and it is therefore more 14 
difficult to cannulate (17). Moreover, despite significant efforts towards standardization, AVS 15 
protocols and interpretation of hormone results vary widely across centers (5,12).  16 
Adrenal vein rupture and subsequent AH represent the most serious complication of AVS. Despite 17 
being now widely recognized that the prevalence of AH is not as high as suggested by historical 18 
reports, the clinical outcomes of this complication have never been systematically investigated and 19 
evidence on the subsequent optimal management is still lacking. 20 
In this study we collected 24 cases of AH through 6 different referral hypertension centers in Italy, 21 
Germany, Japan and Australia and retrospectively investigated the clinical management and the 22 
outcomes in terms of hospital stay, need for medications/interventional procedure and the rate of 23 
complete and permanent destruction of the affected adrenals. Interestingly, as suggested by historical 24 
reports (9) we observed that AH occurred more frequently in the right adrenal vein suggesting that 25 
the anatomy, unfavorable for cannulation, can at least partially account for this difference. In addition, 26 
 11 
the higher number of attempts necessary to cannulate the right adrenal vein may have contributed to 1 
the higher rate of AH. Overall, abdominal pain was the most common symptom associated with the 2 
occurrence of AH and required treatment with strong opioids in the majority of the patients. Follow 3 
up imaging was performed in most patients, mainly by CT scanning. Only in one case was functional 4 
evaluation by adrenal scintiscan performed. In this patient the uptake of the tracer in the adrenal 5 
containing the AH demonstrated that the complication did not result in loss of functional activity of 6 
the gland.  7 
A recent observational retrospective multicenter study (7) showed that the rate of adrenal vein rupture 8 
was inversely correlated with the number of procedures performed by each radiologist and directly 9 
with the number of AVS procedures performed per center. However, in our series AH occurred with 10 
both experienced radiologists (> 5 years of experience and > 10 procedures/year) and inexperienced 11 
ones, consistent with experience of the operator being not the only important factor associated with 12 
the occurrence of AH. 13 
It should be noted that in two patients with AH, AVS was successfully and uneventfully repeated 14 
without complication, showing that a previous AH does not necessary exclude the feasibility of a 15 
subsequent AVS.  16 
The most important finding of this study is represented by the outcome data regarding the residual 17 
function of the affected adrenal. In our series of 24 AH only one patient, after removal of the adrenal 18 
contralateral to the AH, displayed signs and symptoms of adrenal insufficiency, requiring long-term 19 
therapy with replacement doses of hydrocortisone. In another case operated in March 2015 the 20 
synacthen test was slightly suboptimal and the patient will be subsequently re-evaluated by repeat 21 
testing. These findings show that the functional activity of the adrenals after the haemorrhage is in 22 
most cases not markedly impaired by this complication. In agreement with these findings we did not 23 
observe a blood pressure reduction after the AH when the event involved the adrenal bearing the APA 24 
or in BAH patients.  25 
 12 
In clinical practice, when the AH involves the contralateral adrenal to an APA the clinician may be 1 
concerned about the residual adrenal function of the affected adrenal gland and hence whether 2 
corticoisteroid replacement will be required peri-operatively and long-term following unilateral 3 
adrenalectomy. One option is to perform an adrenal-sparing nodulectomy to save part of the 4 
functioning cortex surrounding the APA. However, this surgical option has the potential disadvantage 5 
of PA persisting if the removed nodule was not the sole source of excessive aldosterone production 6 
(18). In fact, aldosterone production outside the main nodule of the removed adrenal was observed in 7 
immunohistochemistry studies using specific antibodies for CYP11B2 (19,20). To overcome this 8 
disadvantage, super selective segmental adrenal vein branches AVS would be required (21). 9 
However, this technique is highly demanding and is only available in few specialized centres (22). In 10 
addition to performing short synacthen testing post-operatively, pre-operative testing for residual 11 
adrenal function in the gland bearing the AH by performing adrenal scintiscan using 131I-nor 12 
cholesterol (NP59) without dexamethasone suppression could be considered. This procedure has been 13 
suggested previously (23) and successfully undertaken in one of our patients (TO-01) before 14 
contralateral adrenalectomy to the AH. Furthermore, the identification of the anatomy of right adrenal 15 
vein by contrast-enhanced multidetector CT before AVS may be helpful to shorten the time required 16 
for AVS performance, thereby reducing the AH risk (11,24). Finally, in some selected cases in which 17 
the clinical, radiological and biochemical information point strongly towards unilateral APA, a case 18 
for avoiding AVS could be made (11,24-28).  19 
The main limitation of the present study is the retrospective nature of data collection; therefore the 20 
evaluation of patients’ outcome after the adrenal haemorrhage was not standardized. 21 
 22 
In conclusion, to the best of our knowledge this represents the first study undertaken primarily to 23 
explore the management and the outcomes of AH occurring during AVS. AH, despite being the most 24 
dreaded complication of AVS, usually has a positive outcome causing minor or no permanent effects 25 
 13 
on adrenal function and should not discourage clinicians from using AVS to correctly diagnose the 1 
PA subtype.  2 
 3 
Perspectives 4 
A wealth of studies clearly demonstrated that PA is the most frequent cause of secondary 5 
hypertension. AVS is the only reliable way of differentiating unilateral PA forms that benefit from 6 
adrenalectomy from bilateral forms that are treated pharmacologically. AVS is currently performed 7 
in few referral centres: one of the obstacles to the wide acceptance of this technique is the invasive 8 
nature of the procedure that in some cases is complicated by AH. In the present study this rare 9 
complication usually had a positive outcome in terms of adrenal function. Therefore, AVS should be 10 
offered to all PA patients that are considered for unilateral adrenalectomy, 11 
 12 
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Novelty and Significance: 6 
 What Is New 7 
• Adrenal haemorrhage (AH) following AVS in primary aldosteronism is a rare event and is 8 
more frequent in the right adrenal than in the left and in older patients. 9 
• None of the patients affected by AH on the side of the adenoma displayed cure of PA or 10 
improvement of hypertension following AH. 11 
• The occurrence of AH required hospitalization or a prolongation of hospitalization 12 
compared to non-complicated procedures and required treatment with strong opioid for 13 
efficient pain management in the majority of patients. 14 
• Only one patient, after removal of the adrenal contralateral to the AH, displayed signs and 15 
symptoms of adrenal insufficiency, requiring long-term therapy with replacement doses of 16 
hydrocortisone. 17 
 18 
 19 
 What Is Relevant 20 
• AH usually has a positive outcome causing either none or only minor permanent effects on 21 
adrenal function. Therefore, AVS should remain the favoured approach to PA subtype 22 
differentiation. 23 
 24 
 18 
Summary  1 
Adrenal haemorrhage is a rare complication of adrenal vein sampling for subtype diagnosis of 2 
primary aldosteronism and usually is followed by a favourable outcome in term of adrenal function. 3 
 4 
Legend to figures. 5 
Figure 1. CT scan just after AVS in patient TO-01.  6 
Panel A: left adrenal gland with a discrete 1 cm-diameter nodule at the lateral gland limb (arrow). 7 
Panel B: right supra-renal space is almost completely filled by an oval hematoma (arrow-head). 8 
Two different cuts are shown because adrenal glands were situated in on different CT planes. 9 
 10 
 11 
 19 
Patients Age at AVS 
(years) 
Sex 
 
SBP/DBP 
(number of 
drugs) 
before AVS 
Experience of the 
radiologist in AVS at the 
time of the AH (years) 
Year of the AH Side of AH Diagnosis 
at AVS 
BR-01 41 M 143/88 (3) 8 2013 Right Left APA 
BR-02 41 M 180/110 (4) 3 1992 Right BAH 
BR-03 45 M 155/105 (3) < 1 1992 Right Right APA 
BR-04 69 M 154/84 (1) < 1 1994 Right BAH 
BR-05 65 M 136/80 (4) < 1 1992 Right BAH 
BR-06 58 F 110/80 (2) < 1 1995 Bilateral BAH 
BR-07 53 M 154/98 (3) 1 1995 Left N.D.* 
BR-08 60 F 162/84 (3) 2 1997 Left Left APA 
BR-09 58 F 141/64 (2) 5 1999 Right BAH 
BR-10 67 M 180/94 (3) 6 2000 Right Left APA 
BR-11 68 M 140/90 (1) 18 2013 Right Left APA 
BR-12 51 M 155/80 (0) 15 2010 Left Right APA 
MU-01 35 F 130/85 (1) 5 2014 Right Right APA 
MU-02 62 F 184/83 (1) <1 2014 Right Right APA 
MU-03 76 M 170/80 (3) <1 2014 Right BAH 
MU-04 55 M 160/103 (2) 5 2012 Right Right APA 
WU-01 52 M 180/100 (3) 7 2000 Right Left APA 
SE-01 63 F 155/87 (1) 8 2008 Right Left APA 
SE-02 66 M 161/86 (2) 10 2010 Left Right APA 
SE-03 55 F 126/79 (4) 7 2009 Right N.D.§ 
SE-04 62 M 140/83 (2) 7 2007 Left Right APA 
SE-05 71 M 158/90 (1) 4 2008 Right BAH 
TO-01 55 M 180/120 (2) 15 2012 Right Left APA 
VE-01 49 M 130/90 (2) 2 2014 Right BAH 
All 57±11 - 153/89 (2) 5.0 [0.6-7.8]    
Table 1. Clinical parameters of patients with adrenal haemorrhage 
* The AVS was repeated and then lateralized to the left; § The AVS was repeated and showed bilateral disease 
SBP =  systolic blood pressure; DBP = diastolic blood pressure; AH = adrenal haemorrhage; CT = computed tomography; N.D. = not diagnostic; AVS = adrenal vein 
sampling .
 20 
Patients Hospitalization requirement (days) Drugs for pain control 
Follow up 
imaging Adrenalectomy 
Same side/ 
CL side 
SBP/DBP (no. 
classes of drugs) 
after AVS/ADX 
BR-01 Yes (1) Morphine s/c, paracetamol CT scan Yes CL side 182/116 (3) 
BR-02 Yes (2) Pethidine, paracetamol CT scan No N.A. 160/80 (4) 
BR-03 Yes (3) Pethidine, omnopon CT scan Yes Same side 156/110 (1) 
BR-04 Yes (1) Pethidine CT scan No N.A. 160/80 (1) 
BR-05 Yes (2) Morphine s/c, paracetamol CT scan No N.A. 192/96 (5) 
BR-06 No Pethidine, paracetamol None No N.A. 130/68 (2) 
BR-07 No None None* Yes Same side 164/88 (2) 
BR-08 Yes (1) Pethidine, paracetamol CT scan Yes Same side 124/84 (0) 
BR-09 Yes (1) Pethidine, paracetamol CT scan No N.A. 157/94 (3) 
BR-10 Yes (5) Codeine, paracetamol CT scan Yes CL side 134/78 (0) 
BR-11 Yes (2) Paracetamol, pethidine CT scan No (nodulectomy) CL side 140/80 (0) 
BR-12 Yes (3) Paracetamol, pethidine CT scan Yes CL side 128/85 (0) 
MU-01 Yes (1) Metamizol None No (nodulectomy) Same side 113/76 (0) 
MU-02 Yes (1) None None Yes Same side 130/85 (0) 
MU-03 Yes (3) Paracetamol CT scan No N.A. 145/65 (3) 
MU-04 Yes (3) Piritramid CT scan Yes Same side 152/96 (4) 
WU-01 Yes (4) Phetidine fentanyl CT scan No (nodulectomy) CL side 140/85 (0) 
SE-01 Yes (1) None None Yes CL side 127/78 (0) 
SE-02 Yes (1) None None Yes CL side 122/79 (0) 
SE-03 Yes (1) None None No N.A. 117/70 (3) 
SE-04 Yes (1) None None Yes CL side 126/82 (1) 
SE-05 Yes (1) None CT scan No N.A. 120/68 (2) 
TO-01 Yes (3) Morphine paracetamol CT scan No (nodulectomy) CL side 135/85 (0) 
VE-01 Yes (4) Tramadol CT and Scinti scan No N.A. 120/80 (1) 
All 1.9±1.3      
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Table 2. Outcome parameters after adrenal haemorrhage. 
*Minor asymptomatic extravasation of contrast was seen at the time of AVS and further imaging was not considered clinically indicated.  
SBP =  systolic blood pressure; DBP = diastolic blood pressure; CT = computed tomography; N.A. = not applicable; AVS = adrenal vein sampling; ADX = 
adrenalectomy.  
